Anna Nowogrodzki is a freelance journalist. Her writing can be found in National Geographic, Smithsonian, Nautilus, and Nature, among other publications, and she can be found in the Boston area on her bicycle.
ᐧ
Anna Nowogrodzki
From this contributor
Mutations tied to autism may alter gut function, microbiome in mice
Mutations in the autism gene NLGN3 may alter the gut nervous system of mice.
Mutations tied to autism may alter gut function, microbiome in mice
By
Anna Nowogrodzki
11 July 2019 | 5 min read
Latest test of promising autism therapy shows only mild benefits
A much-touted behavioral therapy for autism, the Early Start Denver Model, may not be as effective as its creators had hoped.
Latest test of promising autism therapy shows only mild benefits
By
Anna Nowogrodzki
14 March 2019 | 6 min read
Parents beat clinicians at detecting autism signs in infants
Parents who have one child with an autism diagnosis can more accurately spot signs of the condition in their younger child at 12 months of age than clinicians can.
Parents beat clinicians at detecting autism signs in infants
By
Anna Nowogrodzki
12 March 2018 | 4 min read
New method taps family trees for clues about conditions
Asking participants in genetic databases about their family’s medical history can help researchers uncover genetic variants tied to conditions such as autism.
New method taps family trees for clues about conditions
By
Anna Nowogrodzki
10 March 2017 | 2 min read
Explore more from The Transmitter
Exclusive: The 23 studies the FDA based its expanded leucovorin label on
The studies include 46 people, mostly toddlers, who have cerebral folate deficiency due to variants in a folate transporter.
Exclusive: The 23 studies the FDA based its expanded leucovorin label on
The studies include 46 people, mostly toddlers, who have cerebral folate deficiency due to variants in a folate transporter.
By
Claudia López Lloreda
2 October 2025 | 6 min read
Autism researchers ‘pleasantly surprised’ by list of NIH data project grantees, despite initial concerns
An atypical funding mechanism, truncated application timeline and opaque review process had generated concern over the quality of projects that would be selected for the Autism Data Science Initiative.
Autism researchers ‘pleasantly surprised’ by list of NIH data project grantees, despite initial concerns
An atypical funding mechanism, truncated application timeline and opaque review process had generated concern over the quality of projects that would be selected for the Autism Data Science Initiative.
By
Calli McMurray
2 October 2025 | 10 min read
Exclusive: Who is Richard Frye, the neurologist who researches and advocates for leucovorin as an autism treatment?
Frye has led two placebo-controlled trials of the folate supplement in autistic people; the first was suspended by regulators, and the other has yet to be published.
Exclusive: Who is Richard Frye, the neurologist who researches and advocates for leucovorin as an autism treatment?
Frye has led two placebo-controlled trials of the folate supplement in autistic people; the first was suspended by regulators, and the other has yet to be published.
By
Brendan Borrell
1 October 2025 | 11 min read